1132P Utility of circulating tumor DNA (ctDNA) dynamics for evaluating early treatment response in patients with recurrent/metastatic endometrial (rEC) and recurrent/platinum-resistant ovarian cancer (rPROC).
Saved in:
| Title: | 1132P Utility of circulating tumor DNA (ctDNA) dynamics for evaluating early treatment response in patients with recurrent/metastatic endometrial (rEC) and recurrent/platinum-resistant ovarian cancer (rPROC). |
|---|---|
| Authors: | Cosgrove, C.1 (AUTHOR), Backes, F.1 (AUTHOR), Scalise, C.B.2 (AUTHOR), Dwivedi, B.2 (AUTHOR), Chambers, L.1 (AUTHOR), Nagel, C.1 (AUTHOR), Wei, L.3 (AUTHOR), Hays, J.4 (AUTHOR), Salmasi, F.2 (AUTHOR), Dutta, P.2 (AUTHOR), Kalashnikova, E.2 (AUTHOR), Hook, N.2 (AUTHOR), Liu, M.C.2 (AUTHOR), ElNaggar, A.C.2 (AUTHOR), O'Malley, D.1 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS752-S753. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.1768 |
